WO1997030685A1 - Bain de bouche a teneur alcoolique reduite - Google Patents
Bain de bouche a teneur alcoolique reduite Download PDFInfo
- Publication number
- WO1997030685A1 WO1997030685A1 PCT/US1996/002480 US9602480W WO9730685A1 WO 1997030685 A1 WO1997030685 A1 WO 1997030685A1 US 9602480 W US9602480 W US 9602480W WO 9730685 A1 WO9730685 A1 WO 9730685A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- reduced alcohol
- reduced
- mouthwash composition
- antimicrobial mouthwash
- Prior art date
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims abstract description 205
- 239000002324 mouth wash Substances 0.000 title claims abstract description 139
- 229940051866 mouthwash Drugs 0.000 title claims abstract description 122
- 230000002829 reductive effect Effects 0.000 title claims abstract description 88
- 239000000203 mixture Substances 0.000 claims abstract description 153
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 84
- 229920005862 polyol Polymers 0.000 claims abstract description 47
- 150000003077 polyols Chemical class 0.000 claims abstract description 47
- 239000000341 volatile oil Substances 0.000 claims abstract description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 33
- 208000024693 gingival disease Diseases 0.000 claims abstract description 12
- 230000009467 reduction Effects 0.000 claims abstract description 9
- 239000004599 antimicrobial Substances 0.000 claims abstract description 6
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims description 51
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 36
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 35
- 239000000600 sorbitol Substances 0.000 claims description 35
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims description 30
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 claims description 30
- 239000000796 flavoring agent Substances 0.000 claims description 27
- 235000019634 flavors Nutrition 0.000 claims description 27
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 25
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 21
- 239000005844 Thymol Substances 0.000 claims description 21
- 229960000790 thymol Drugs 0.000 claims description 21
- 239000003921 oil Substances 0.000 claims description 16
- 229940011037 anethole Drugs 0.000 claims description 15
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 claims description 15
- 239000004615 ingredient Substances 0.000 claims description 14
- 229960001047 methyl salicylate Drugs 0.000 claims description 14
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 claims description 13
- 229960005233 cineole Drugs 0.000 claims description 13
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 12
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 claims description 12
- 235000011187 glycerol Nutrition 0.000 claims description 12
- 229940041616 menthol Drugs 0.000 claims description 11
- 150000005846 sugar alcohols Chemical class 0.000 claims description 11
- 229920001983 poloxamer Polymers 0.000 claims description 9
- -1 alkylene glycols Chemical class 0.000 claims description 8
- 239000002736 nonionic surfactant Substances 0.000 claims description 7
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 239000000975 dye Substances 0.000 claims description 5
- 239000000872 buffer Substances 0.000 claims description 4
- 229960000502 poloxamer Drugs 0.000 claims description 4
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 claims description 2
- 150000002009 diols Chemical class 0.000 claims description 2
- 229920001992 poloxamer 407 Polymers 0.000 claims description 2
- 229940044476 poloxamer 407 Drugs 0.000 claims description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims 5
- 108010009736 Protein Hydrolysates Proteins 0.000 claims 1
- 206010006326 Breath odour Diseases 0.000 abstract description 10
- 210000000214 mouth Anatomy 0.000 abstract description 9
- 230000002265 prevention Effects 0.000 abstract description 6
- 235000010356 sorbitol Nutrition 0.000 description 23
- 238000003556 assay Methods 0.000 description 18
- 239000000243 solution Substances 0.000 description 17
- 235000019198 oils Nutrition 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 230000002421 anti-septic effect Effects 0.000 description 13
- 244000005700 microbiome Species 0.000 description 12
- 235000019640 taste Nutrition 0.000 description 11
- 239000004094 surface-active agent Substances 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000002158 endotoxin Substances 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 229940076522 listerine Drugs 0.000 description 9
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 7
- 239000003906 humectant Substances 0.000 description 7
- 238000000338 in vitro Methods 0.000 description 7
- 239000008367 deionised water Substances 0.000 description 6
- 229910021641 deionized water Inorganic materials 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 230000035515 penetration Effects 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 208000002064 Dental Plaque Diseases 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- XJRPTMORGOIMMI-UHFFFAOYSA-N ethyl 2-amino-4-(trifluoromethyl)-1,3-thiazole-5-carboxylate Chemical compound CCOC(=O)C=1SC(N)=NC=1C(F)(F)F XJRPTMORGOIMMI-UHFFFAOYSA-N 0.000 description 4
- 208000007565 gingivitis Diseases 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 239000005711 Benzoic acid Substances 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 235000010233 benzoic acid Nutrition 0.000 description 3
- 229920001400 block copolymer Polymers 0.000 description 3
- 125000002091 cationic group Chemical group 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 235000019477 peppermint oil Nutrition 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 241000194019 Streptococcus mutans Species 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 230000002882 anti-plaque Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 2
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000000989 food dye Substances 0.000 description 2
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 235000014666 liquid concentrate Nutrition 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229940095518 mouthwash product Drugs 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000007793 ph indicator Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229960003500 triclosan Drugs 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- AZXBHGKSTNMAMK-UHFFFAOYSA-N 3-methyl-2-propan-2-ylphenol Chemical compound CC(C)C1=C(C)C=CC=C1O AZXBHGKSTNMAMK-UHFFFAOYSA-N 0.000 description 1
- 241000606749 Aggregatibacter actinomycetemcomitans Species 0.000 description 1
- FBPFZTCFMRRESA-FBXFSONDSA-N Allitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-FBXFSONDSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Camphene hydrate Chemical compound C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 235000019499 Citrus oil Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KAZBKCHUSA-N D-altritol Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 description 1
- FBPFZTCFMRRESA-ZXXMMSQZSA-N D-iditol Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-ZXXMMSQZSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 description 1
- 241000605986 Fusobacterium nucleatum Species 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 240000004760 Pimpinella anisum Species 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- JVWLUVNSQYXYBE-UHFFFAOYSA-N Ribitol Natural products OCC(C)C(O)C(O)CO JVWLUVNSQYXYBE-UHFFFAOYSA-N 0.000 description 1
- 208000010641 Tooth disease Diseases 0.000 description 1
- 241001148135 Veillonella parvula Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WXBLLCUINBKULX-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1.OC(=O)C1=CC=CC=C1 WXBLLCUINBKULX-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000004287 bisbiguanides Chemical class 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 239000010500 citrus oil Substances 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013766 direct food additive Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000011013 endotoxin removal Methods 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- FBPFZTCFMRRESA-UHFFFAOYSA-N hexane-1,2,3,4,5,6-hexol Chemical compound OCC(O)C(O)C(O)C(O)CO FBPFZTCFMRRESA-UHFFFAOYSA-N 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 229960004873 levomenthol Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910001120 nichrome Inorganic materials 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- HEBKCHPVOIAQTA-ZXFHETKHSA-N ribitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CO HEBKCHPVOIAQTA-ZXFHETKHSA-N 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 235000019654 spicy taste Nutrition 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Definitions
- Listerine ® -brand mouthwash is a well-known antiseptic mouthwash that has been used by millions of people for over one hundred years and has been proven effective in killing microbes in the oral cavity that are responsible for plaque, gingivitis and bad breath.
- Thymol together with other essential oils such as methyl salicylate, menthol and eucalyptol, are active ingredients in antiseptic mouth rinses such as Listerine ® . These oils achieve their efficacy although present in small amounts. Without being restricted to any specific theory, it is now believed that the efficacy and taste of antiseptic mouthwashes such as Listerine ® may be due to the dissolution of these four active ingredients.
- the amount of polyols employed is generally inversely proportional to the amount of ethanol; that is, as the level of ethanol is reduced below about 22% v/v, it is generally necessary to increase the concentration of polyols beyond about 18% w/v to maintain good antimicrobial efficacy.
- a reduced alcohol, antimicrobial mouthwash composition which comprises (a) an antimicrobially effective amount of one or more essential oils; (b) a reduced level, up to about 22% v/v, of ethanol; (c) at least about 18% w/v of one or more polyols sufficient to provide an enhanced antimicrobial activity of said essential oils at said reduced level of ethanol, such that the R-Factor (defined below) of said mouthwash composition is less than about 2.0, preferably less than about 1.2, and most preferably less than about 1.0; and (d) water.
- reduced level of alcohol is meant an amount of ethanol up to about 22% v/v, such as an amount of from about 9% v/v to about 22% v/v,
- the ratio of water to ethanol is in the range of from about 3:1 to about 25:1, preferably from about 3.2:1 to about 10:1, by volume.
- Suitable flavors include oil of anise (about 0.01% w/v to about 0.2% w/v) and benzyl alcohol (about 0.001% w/v to about 0.1% w/v).
- the mouthwash is a clear, green color and further includes spearmint oil (about 0.01% w/v to about 2.0% w/v) as an additional flavorant.
- spearmint oil about 0.01% w/v to about 2.0% w/v
- Other flavors such as citrus oils, vanillin and the like may be incorporated to provide further taste variations.
- a mouthwash composition that is totally free of anethole or at least essentially free of anethole (i.e., trace amounts or amounts which are so small as to not contribute functionally to the taste or flavor properties of the composition).
- the particular flavor oils and other taste-improving ingredients employed will vary depending upon the particular taste and feel desired. Those skilled in the art can select and customize these types of ingredients to provide the desired results.
- Zinc chloride may be added as an astringent for an "antiseptic cleaning" feeling in an amount of from about 0.0025% w/v to about 0.0075% w/v.
- the mouthwash formulations of the present invention may be formulated to be substantially clear and colorless, acceptably approved food dyes are preferably used to provide a pleasing color to the formulations of the invention. These may be selected from the long list of acceptable food dyes and in particular may be
- the mouthwash composition of the present invention may also be formulated, if desired, as gels, foams, pastes,
- the mouthwash compositions of the present invention may be formulated in a dry powder, chewing gum, semi-solid, solid or liquid concentrate form.
- water is added to q.s. the volume to the necessary total for a liquid concentrate, or water may be removed using standard evaporation procedures known in the art to prepare a composition in dry powder form. Both may then have water added at a later date when ready for use.
- Such forms are advantageous for storage and shipping.
- Jordan's medium with pH indicator (“recovery medium”) is prepared by adding 1 ml of a 1% bromocresol purple stock solution (i.e., 0.1 gram bromocresol purple in 10 mis distilled water) to 1 liter of
- the culture for the assay is prepared as follows. Upon receipt, the ATCC culture is rehydrated and subcultured according to the directions supplied by the American Type Culture Collection. The subculture is streaked for purity on Brain-Heart Infusion Agar (DIFCO) and inoculated into 100 ml of sterile BHI. The agar plates are examined for purity after 14-18 hours. If
- test tubes are then incubated anaerobically overnight (i.e., 14-16 hours) at 37°C.
- the number of test tubes will vary depending upon the number of different mouthwash samples being tested, but it will be convenient to describe an assay of a
- mouthwash with the succeeding four sets of three tubes each in that row being reserved for the four reduced alcohol samples. There are three tubes in each set because each assay is performed in triplicate.
- plaque wires are then transferred into fresh Jordan's medium in 75 tubes (in a second rack) and again incubated anaerobically for 24 hours at 37°C. This procedure is repeated once more.
- the plaque wires are cultured for 3 days, with two transfers after initial inoculation.
- additional racks are prepared: a first (assay) rack whose test tubes each contain 6 ml of the sample mouthwashes; a second (water) rack whose test tubes each contain 6 ml of sterile deionized water; third and fourth racks whose test tubes each contain 6 ml of Letheen broth rinse; and a fifth rack whose test tubes each contain 5 ml of Jordan's recovery medium.
- the racks may be marked for test series identity and time (by row).
- Assay Procedure Each assay will involve triplicate testing at time points separated by one minute
- intervals e.g., at 2, 3, 4, 5 and 6 minutes of
- the exact time of exposure of the plaque wires to the sample mouthwashes can be varied according to the thickness of the "plaques;” ideally, the exposure period will result in positive microorganism growth in the first one or two sampling intervals of the high alcohol control group, (i.e., the first and second row) and no growth thereafter.
- Mouthwash exposure takes place in a 37° New Brunswick shaking water bath (shake speed 3) and may be staggered so that the 5 time points are run concurrently, but with sufficient time to permit accurate timing and handling.
- Positive growth is indicated by a color change from purple to yellow (i.e., if the microorganism is still viable, it will produce an acid which causes the color change); positive growth is often accompanied by an increase in broth turbidity.
- each mouthwash sample is located in the same set of three tubes in each row of the rack, the critical time necessary for the sample to completely kill the microorganism can be determined by observing the point (front to back or bottom to top, as the case may be) at which the Jordan recovery medium color changed from yellow to purple.
- the critical kill time for any sample divided by the critical kill time for the control mouthwash in that same rack, gives the R-Factor for that sample.
- Table 2 summarizes a statistical scale developed by the present inventors which relates the observed change from growth (+) to no growth (-) to critical kill times. For example, as shown in the first row of Table 2, where the observed condition changes from growth (continuous +'s) to no growth (continuous -'s) ("no anomaly"), the critical kill time is determined by adding 0.50 minute to the time at which the last growth observation (+) was made. The balance of Table 2 sets forth how critical kill times are determined for different observed growth/no growth intervals between continuous growth segments and continuous no growth segments.
- a mouthwash composition containing 19% v/v ethanol and 18% w/v sorbitol was prepared as follows. First, an alcohol solution of active essential oils and flavor oils was prepared by dissolving the ingredients listed in Table 4 in 200 mls of ethanol (USP): To the resulting alcohol solution were then added the additional ingredients shown in Table 5 (along with suitable dyes to obtain the desired color):
- the pH was adjusted to 4.2. Approximately 600 mls of deionized water was then added, and the solution was mixed until all solids were dissolved. Additional deionized water was added with mixing to bring the total solution to 1 liter. A clear mouthwash solution was obtained.
- Example 2 A number of different mouthwash compositions A-J were prepared. The composition ingredients and amounts used (except for the dyes) are shown in Table 6 below.
- the mouthwashes were prepared as follows. An alcohol solution was prepared by dissolving the flavor oils, part of the thymol and part of the methyl salicylate in 227 or 200 milliters of ethanol (USP). Into the resulting solution was then dissolved the remaining methyl salicylate, the remaining thymol, the benzoic acid and the Pluronic surfactant. 300 mis of the deionized water was then slowly added to the resulting solution, with mixing. The sorbitol (USP) solution, or propylene glycol, was then added, with continued mixing, followed by the sodium saccharin, the sodium citrate and the citric acid, with mixing until
- Endotoxin is a component of the outer wall of Gram negative bacteria and if shed by the bacteria at or near infection sites about the teeth and gums will elicit inflammation and gingivitis. Removal of
- Control mouthwash was the high alcohol (27% v/v) standard described above.
- mouthwash clearly decrease the degree of endotoxin remaining in the culture, supporting its value in preventing inflammation and subsequent gum disease.
- plaque penetration assay (described above) -- was employed in this invention.
- the results of this assay reported as "Critical Kill Times" (or "CKT"), are more predictive of the in vivo effect of oral mouthrinses than endotoxin measurements.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Abstract
L'invention a trait à une composition antimicrobienne pour bains de bouche, efficace pour prévenir et atténuer la mauvaise haleine, la plaque dentaire et les affections gingivales connexes, comportant une quantité efficace sur le plan antimicrobien d'une ou de plusieurs huiles essentielles actives, une concentration réduite, allant jusqu'à 22 % en poids volume, d'alcool, des concentrations renforcées, d'au moins 18 % en poids volume d'un ou de plusieurs polyols augmentant l'efficacité des substances actives dans la cavité buccale et de l'eau. Ces substances actives non seulement renforcent l'efficacité du produit mais sont, de surcroît, entièrement dissoutes dans de faibles concentrations d'éthanol, ce qui donne au produit un aspect attrayant.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1996/002480 WO1997030685A1 (fr) | 1996-02-23 | 1996-02-23 | Bain de bouche a teneur alcoolique reduite |
AU53552/96A AU5355296A (en) | 1996-02-23 | 1996-02-23 | Reduced alcohol mouthwash |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1996/002480 WO1997030685A1 (fr) | 1996-02-23 | 1996-02-23 | Bain de bouche a teneur alcoolique reduite |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997030685A1 true WO1997030685A1 (fr) | 1997-08-28 |
Family
ID=22254757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/002480 WO1997030685A1 (fr) | 1996-02-23 | 1996-02-23 | Bain de bouche a teneur alcoolique reduite |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5355296A (fr) |
WO (1) | WO1997030685A1 (fr) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6261540B1 (en) * | 1997-10-22 | 2001-07-17 | Warner-Lambert Company | Cyclodextrins and hydrogen peroxide in dental products |
US6348187B1 (en) * | 1996-01-24 | 2002-02-19 | Warner-Lambert Company | Peroxide/essential oils containing mouthwash compositions and two-part mouthwash systems |
FR2905065A1 (fr) * | 2006-08-24 | 2008-02-29 | Tonino Vilia | Composition cosmetique universelle aromatique a pouvoir regenerant pour le bien etre du corps |
US7601731B2 (en) * | 2003-06-06 | 2009-10-13 | Board Of Regents, The University Of Texas System | Antimicrobial flush solutions |
EP1774953A3 (fr) * | 2005-10-17 | 2010-01-20 | Henkel AG & Co. KGaA | Collutoire concentré |
EP1774955A3 (fr) * | 2005-10-17 | 2010-02-17 | Henkel AG & Co. KGaA | Collutoire prêt-à-l'emploi |
US20120003163A1 (en) * | 2010-06-30 | 2012-01-05 | Mcneil-Ppc, Inc. | Non-Alchohol Bioactive Essential Oil Mouth Rinses |
CN102309424A (zh) * | 2010-06-30 | 2012-01-11 | 麦克内尔-Ppc股份有限公司 | 制备无醇生物活性精油漱口液的方法 |
WO2022109261A3 (fr) * | 2020-11-20 | 2022-07-21 | Howard Frysh | Élimination de tartre dentaire |
CN119678946A (zh) * | 2025-02-21 | 2025-03-25 | 温州医科大学附属第一医院 | 采用saew协同百里酚的抗菌消毒方法及其产品 |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3250681A (en) * | 1961-12-04 | 1966-05-10 | Celanese Corp | Ethylidene diacetate as bacteriostat in cosmetic and other compositions |
EP0338978A2 (fr) * | 1988-03-31 | 1989-10-25 | Warner-Lambert Company | Masquage du goût du thymol |
EP0373758A2 (fr) * | 1988-12-14 | 1990-06-20 | Warner-Lambert Company | Compositions antiseptiques contenant des dérivés de la hexahydro-5-pyrimidine-amine et du thymol et leur procédé de préparation |
EP0497476A2 (fr) * | 1991-01-30 | 1992-08-05 | Colgate-Palmolive Company | Compositions orales antiplaques |
WO1994007477A1 (fr) * | 1992-10-07 | 1994-04-14 | Warner-Lambert Company | Masquage du gout du thymol |
WO1994018939A1 (fr) * | 1993-02-19 | 1994-09-01 | Warner-Lambert Company | Composition de rinçage utilisee avant le brossage |
WO1994027566A1 (fr) * | 1993-05-20 | 1994-12-08 | Warner-Lambert Company | Arome peppermint ameliore pour produits d'hygiene orale |
DE4418796A1 (de) * | 1993-06-02 | 1994-12-15 | Colgate Palmolive Co | Oral anwendbare und gegen Plaque und Gingivitis wirkende Zusammensetzungen |
WO1995034276A1 (fr) * | 1994-06-10 | 1995-12-21 | The Procter & Gamble Company | Compositions de bain de bouche |
EP0692246A1 (fr) * | 1994-07-15 | 1996-01-17 | Colgate-Palmolive Company | Compositions orales |
WO1996015770A1 (fr) * | 1994-11-17 | 1996-05-30 | Warner-Lambert Company | Compositions antimicrobiennes orales |
WO1996016633A1 (fr) * | 1994-12-02 | 1996-06-06 | Warner-Lambert Company | Bain de bouche a teneur reduite en alcool |
-
1996
- 1996-02-23 WO PCT/US1996/002480 patent/WO1997030685A1/fr active Application Filing
- 1996-02-23 AU AU53552/96A patent/AU5355296A/en not_active Abandoned
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3250681A (en) * | 1961-12-04 | 1966-05-10 | Celanese Corp | Ethylidene diacetate as bacteriostat in cosmetic and other compositions |
EP0338978A2 (fr) * | 1988-03-31 | 1989-10-25 | Warner-Lambert Company | Masquage du goût du thymol |
US4945087A (en) * | 1988-03-31 | 1990-07-31 | Warner-Lambert Company | Taste masking of thymol |
EP0373758A2 (fr) * | 1988-12-14 | 1990-06-20 | Warner-Lambert Company | Compositions antiseptiques contenant des dérivés de la hexahydro-5-pyrimidine-amine et du thymol et leur procédé de préparation |
EP0497476A2 (fr) * | 1991-01-30 | 1992-08-05 | Colgate-Palmolive Company | Compositions orales antiplaques |
WO1994007477A1 (fr) * | 1992-10-07 | 1994-04-14 | Warner-Lambert Company | Masquage du gout du thymol |
WO1994018939A1 (fr) * | 1993-02-19 | 1994-09-01 | Warner-Lambert Company | Composition de rinçage utilisee avant le brossage |
WO1994027566A1 (fr) * | 1993-05-20 | 1994-12-08 | Warner-Lambert Company | Arome peppermint ameliore pour produits d'hygiene orale |
DE4418796A1 (de) * | 1993-06-02 | 1994-12-15 | Colgate Palmolive Co | Oral anwendbare und gegen Plaque und Gingivitis wirkende Zusammensetzungen |
WO1995034276A1 (fr) * | 1994-06-10 | 1995-12-21 | The Procter & Gamble Company | Compositions de bain de bouche |
EP0692246A1 (fr) * | 1994-07-15 | 1996-01-17 | Colgate-Palmolive Company | Compositions orales |
WO1996015770A1 (fr) * | 1994-11-17 | 1996-05-30 | Warner-Lambert Company | Compositions antimicrobiennes orales |
WO1996016633A1 (fr) * | 1994-12-02 | 1996-06-06 | Warner-Lambert Company | Bain de bouche a teneur reduite en alcool |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6348187B1 (en) * | 1996-01-24 | 2002-02-19 | Warner-Lambert Company | Peroxide/essential oils containing mouthwash compositions and two-part mouthwash systems |
US6261540B1 (en) * | 1997-10-22 | 2001-07-17 | Warner-Lambert Company | Cyclodextrins and hydrogen peroxide in dental products |
US8709342B2 (en) | 2003-06-06 | 2014-04-29 | Board Of Regents, The University Of Texas System | Antimicrobial flush solutions |
US9078441B2 (en) | 2003-06-06 | 2015-07-14 | Board Of Regents, The University Of Texas System | Antimicrobial flush solutions |
US7601731B2 (en) * | 2003-06-06 | 2009-10-13 | Board Of Regents, The University Of Texas System | Antimicrobial flush solutions |
EP1774953A3 (fr) * | 2005-10-17 | 2010-01-20 | Henkel AG & Co. KGaA | Collutoire concentré |
EP1774955A3 (fr) * | 2005-10-17 | 2010-02-17 | Henkel AG & Co. KGaA | Collutoire prêt-à-l'emploi |
FR2905065A1 (fr) * | 2006-08-24 | 2008-02-29 | Tonino Vilia | Composition cosmetique universelle aromatique a pouvoir regenerant pour le bien etre du corps |
US20120003163A1 (en) * | 2010-06-30 | 2012-01-05 | Mcneil-Ppc, Inc. | Non-Alchohol Bioactive Essential Oil Mouth Rinses |
CN102309424A (zh) * | 2010-06-30 | 2012-01-11 | 麦克内尔-Ppc股份有限公司 | 制备无醇生物活性精油漱口液的方法 |
US20140322146A1 (en) * | 2010-06-30 | 2014-10-30 | Mcneil-Ppc, Inc. | Methods of preparing non-alcohol bioactive essential oil mouth rinses |
US9084902B2 (en) | 2010-06-30 | 2015-07-21 | Mcneil-Ppc, Inc. | Non-alchohol bioactive essential oil mouth rinses |
US9693944B2 (en) | 2010-06-30 | 2017-07-04 | Johnson & Johnson Consumer Inc. | Methods of preparing non-alcohol bioactive essential oil mouth rinses |
US9763863B2 (en) | 2010-06-30 | 2017-09-19 | Johnson & Johnson Consumer Inc. | Methods of preparing non-alcohol bioactive essential oil mouth rinses |
US10434050B2 (en) | 2010-06-30 | 2019-10-08 | Johnson & Johnson Consumer Inc. | Methods of preparing non-alcohol bioactive essential oil mouth rinses |
US10993894B2 (en) | 2010-06-30 | 2021-05-04 | Johnson & Johnson Consumer Inc. | Methods of preparing non-alcohol bioactive essential oil mouth rinses |
WO2022109261A3 (fr) * | 2020-11-20 | 2022-07-21 | Howard Frysh | Élimination de tartre dentaire |
CN119678946A (zh) * | 2025-02-21 | 2025-03-25 | 温州医科大学附属第一医院 | 采用saew协同百里酚的抗菌消毒方法及其产品 |
Also Published As
Publication number | Publication date |
---|---|
AU5355296A (en) | 1997-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6348187B1 (en) | Peroxide/essential oils containing mouthwash compositions and two-part mouthwash systems | |
US5891422A (en) | Antimicrobial composition containing a C3 -C6 alcohol | |
US5817295A (en) | Alcohol free mouthwash | |
US5723106A (en) | Reduced alcohol mouthwash antiseptic and antiseptic preparation | |
US6121315A (en) | Oral compositions containing a zinc compound | |
US5284648A (en) | Alcohol-free, oral rinse and pre-rinse emulsions method of prepration and method of use | |
EP0854702B1 (fr) | Compositions antimicrobiennes contenant un alcool c 3-c 6 | |
US9622962B2 (en) | Oral care product and methods of use and manufacture thereof | |
US20100178256A1 (en) | Oral anti-odor compositions | |
EP1069824B1 (fr) | Compositions orales antimicrobiennes et anti-odeurs | |
WO1996016633A1 (fr) | Bain de bouche a teneur reduite en alcool | |
WO1997030685A1 (fr) | Bain de bouche a teneur alcoolique reduite | |
KR20120112538A (ko) | 유화형 액체 구강용 조성물 및 그 제조 방법 | |
JP3582571B2 (ja) | 口腔液体製剤 | |
JP2004238375A (ja) | 殺菌性口腔用組成物 | |
KR100759518B1 (ko) | 구취 억제용 구강 조성물 | |
US20030175216A1 (en) | Oral antimicrobial and anti-odor compositions | |
JP2000053546A (ja) | 洗口剤 | |
BR112013011852B1 (pt) | Two-phase mouthwash and its use in the preparation of a medicament for treating diseases and disorders in oral health |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP MX NZ SG |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 97530094 Format of ref document f/p: F |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
122 | Ep: pct application non-entry in european phase |